Pathologic Response to Neoadjuvant Chemotherapy in HPV‐associated Oropharynx Cancer
Head & neck(2019)
摘要
A paradigm shift has led to de‐escalation trials for the treatment of HPV‐positive oropharynx cancer (OPC). The objective of this study was to assess the ability of tumor volume reduction on imaging to predict pathological response to neoadjuvant chemotherapy in patients with HPV‐positive OPC.
更多查看译文
关键词
HPV,MRI,neoadjuvant chemotherapy,oropharynx cancer,transoral surgery
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要